Successful treatment of posttraumatic stress disorder with prazosin in a young child

Annals of Pharmacotherapy

Volumn 45, Issue 12, 2011, Pages 1590-1591

  Strawn, Jeffrey R ^a   Keeshin, Brooks R ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMETHYLPHENIDATE; PRAZOSIN;

ADD ON THERAPY; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BODY MASS; CASE REPORT; CHILD; CHILD PSYCHIATRY; CHILD SEXUAL ABUSE; CHILDHOOD DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; DIZZINESS; HUMAN; HYPOTENSION; INSOMNIA; LETTER; MALE; MORNING DOSAGE; NIGHTMARE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; PSYCHOTRAUMA; SCHOOL CHILD; SIDE EFFECT; SLEEP AROUSAL DISORDER; WEIGHT GAIN;

CHILD; DOUBLE-BLIND METHOD; DREAMS; HUMANS; MALE; PRAZOSIN; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS DISORDERS, POST-TRAUMATIC;

EID: 83155193286     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q548     Document Type: Letter

References (5)

1. Strawn JR, Keeshin BR, DelBello MP, Geracioti TD Jr, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents: a review. J Clin Psychiatry 2010;71:932-41.
2. Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008;25:260-71.
3. Pervanidou P, Kolaitis G, Charitaki S, et al. The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol Psychiatry 2007;62:1095-102.
4. Strawn JR, Delbello MP, Geracioti TD. Prazosin treatment of an adolescent with posttraumatic stress disorder. J Child Adolesc Psychopharmacol 2009;19:599-600.
5. Rudolph CD. Rudolph's pediatrics. 21st ed. New York: McGraw-Hill, Medical Publishing Division, 2003.